Kairos Pharma (KAPA) Income Statement (2023 - 2026)
Income Statement report data from Sep 30, 2023 to Mar 31, 2026 for Kairos Pharma (KAPA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||
Total Revenue | 40K (-20.00%) | 50K (+25.00%) | 40K (+33.33%) | 30K | - | - | - | - | - | - |
Operating Expenses | ||||||||||
Research And Development | 680K (+25.93%) | 540K (-11.48%) | 610K (+22.00%) | 500K (+2.04%) | 490K (+188.24%) | 170K (+1600.00%) | 10K (-83.33%) | 60K (-64.71%) | 170K (+466.67%) | 30K |
Selling General And Administrative | 1.01M (+14.77%) | 880K (+6.02%) | 830K (-13.54%) | 960K (+24.68%) | 770K (-39.84%) | 1.28M (+245.95%) | 370K (+131.25%) | 160K (+33.33%) | 120K (-52.00%) | 250K |
Operating Expenses | 1.69M (+19.01%) | 1.42M (-1.39%) | 1.44M (-1.37%) | 1.46M (+14.96%) | 1.27M (-12.41%) | 1.45M (+281.58%) | 380K (+72.73%) | 220K (-24.14%) | 290K (0.00%) | 290K |
Operating Income | ||||||||||
Operating Income | -1.69M (+19.86%) | -1.41M (-1.40%) | -1.43M (-2.05%) | -1.46M (+14.96%) | -1.27M (-12.41%) | -1.45M (+281.58%) | -380.00K (+72.73%) | -220.00K (-24.14%) | -290.00K (0.00%) | -290.00K |
Ebit | -1.69M (+19.86%) | -1.41M (-1.40%) | -1.43M (-2.05%) | -1.46M (+14.96%) | -1.27M (-12.41%) | -1.45M (+281.58%) | -380.00K (+72.73%) | -220.00K (-24.14%) | -290.00K (0.00%) | -290.00K |
EBITDA | -1.65M (+21.32%) | -1.36M (-2.86%) | -1.40M (-1.41%) | -1.42M (+12.70%) | -1.26M (+28.57%) | -980.00K (-4.85%) | -1.03M (+329.17%) | -240.00K (-22.58%) | -310.00K (+3.33%) | -300.00K |
Other Income / Expenses | ||||||||||
Interest Expense | - | - | - | - | - | - | 10K (0.00%) | 10K (-50.00%) | 20K (0.00%) | 20K |
Other Non Operating Income | 40K (-69.23%) | 130K (+225.00%) | 40K (+33.33%) | 30K | - | -260.00K (-60.61%) | -660.00K (+2100.00%) | -30.00K (-25.00%) | -40.00K (+100.00%) | -20.00K |
Net Income | ||||||||||
Net Income From Continuing Operations | -1.65M (+21.32%) | -1.36M (-2.86%) | -1.40M (-1.41%) | -1.42M (+12.70%) | -1.26M (+28.57%) | -980.00K (-6.67%) | -1.05M (+320.00%) | -250.00K (-21.88%) | -320.00K (+3.23%) | -310.00K |
Net Income | -1.65M (+21.32%) | -1.36M (-2.86%) | -1.40M (-1.41%) | -1.42M (+12.70%) | -1.26M (+28.57%) | -980.00K (-6.67%) | -1.05M (+320.00%) | -250.00K (-21.88%) | -320.00K (+3.23%) | -310.00K |